Caricamento...
Ofatumumab treatment in lupus nephritis patients
Rituximab is frequently used in systemic lupus erythematosus; however, side effects such as infusion-related reactions limit its use. In this case report, we describe, for the first time, treatment with ofatumumab in four patients with lupus nephritis. The treatment was well tolerated in three of th...
Salvato in:
| Pubblicato in: | Clin Kidney J |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4957712/ https://ncbi.nlm.nih.gov/pubmed/27478595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfw022 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|